Impact of Palliative Gastrojejunostomy Type on Survival in Patients with Unresectable Pancreatic Head Cancer: A Retrospective Analysis
Open Access
- 31 January 2026
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 326
Abstract
Gastrojejunostomy (GJ) is used as a palliative procedure in patients with inoperable pancreatic head cancer. While its primary goal is to relieve obstruction, clinical observations suggest the type of reconstruction may influence survival. Objectives: The objective of this study was to compare overall survival in patients undergoing different types of palliative gastrojejunostomy. Methods: A retrospective analysis was performed on 240 patients with inoperable pancreatic cancer. Patients were divided into three groups: Roux-en-Y (n = 186), Omega loop with Braun anastomosis (n = 36), and simple Omega loop (n = 18). A multivariable Cox proportional hazards model was used to assess the risk of death, adjusting for age and sex. Results: In the multivariable analysis, the Roux-en-Y anastomosis was associated with a significantly lower risk of death compared to the simple Omega loop (HR = 0.47; 95% CI: 0.28–0.79; p = 0.004). Similarly, the Omega loop with Braun anastomosis demonstrated a significant survival benefit compared to the simple Omega loop (HR = 0.50; 95% CI: 0.27–0.93; p = 0.029). Age was a significant independent predictor of mortality. Conclusions: The type of gastrojejunostomy significantly influences survival in patients with advanced pancreatic cancer. Both Roux-en-Y and Omega with Braun anastomosis offer superior survival outcomes compared to simple Omega loop gastrojejunostomy. These benefits may be attributable to complex metabolic and hormonal mechanisms, which warrant further investigation in prospective studies.Keywords
This publication has 19 references indexed in Scilit:
- A Meta‐Analysis of Endoscopic Stenting Versus Surgical Treatment for Malignant Gastric Outlet ObstructionWorld Journal of Surgery, 2023
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1Cell Metabolism, 2018
- Fate, activity, and impact of ingested bacteria within the human gut microbiotaTrends in Microbiology, 2015
- Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgeryThe Lancet Diabetes & Endocrinology, 2014
- A Meta-Analysis of Randomized Trials: Immediate Stent Placement vs. Surgical Bypass in the Palliative Management of Malignant Biliary ObstructionJournal of Pain and Symptom Management, 2014
- Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cellsMetabolism, 2014
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone ActionCell Metabolism, 2013
- Malignant distal biliary obstruction: A systematic review and meta-analysis of endoscopic and surgical bypass resultsCancer Treatment Reviews, 2007
- The biology of incretin hormonesCell Metabolism, 2006
- Human Pancreatic Cancer Growth Is Inhibited by Peptide YY and BIM-43004-1Journal of Surgical Research, 1995